The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.

The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.

Item
http://www.wikidata.org/entity/Q46248679
Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes.Probiotics--interactions with bile acids and impact on cholesterol metabolism.A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells.Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics.Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat.Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes.Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulationsBile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients
P2860

The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.

Item
http://www.wikidata.org/entity/Q46248679
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@en
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@nl
type
label
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@en
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@nl
prefLabel
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@en
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The influence of 3alpha,7alpha ...... ls in a rat model of diabetes.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698